WallStreetZenWallStreetZen

NASDAQ: PMCB
Pharmacyte Biotech Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PMCB earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$11.5M
Current Profit Margin
0%

PMCB Return on Equity

Current Company
-25.1%
Current Industry
-63.5%
Current Market
188%
PMCB's Return on Equity (-25.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PMCB announces earnings.

PMCB Return on Assets

Current Company
-15.2%
Current Industry
2.9%
PMCB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PMCB Return on Capital Employed

Current Company
-1.79%
Current Industry
19.5%
PMCB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PMCB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PMCB$0.00-$1.14M-$11.51MN/AN/A
PHGE$0.00-$22.87M-$26.17MN/AN/A
BIOR$4.00k-$113.84M-$124.12M-87.44%N/A
AKTX$0.00-$10.00M-$10.01MN/AN/A
TCRT$5.00k-$30.62M-$35.14M-49.08%N/A
View Top Biotech Stocks

Pharmacyte Biotech Earnings & Revenue FAQ

What were PMCB's earnings last quarter?

On Invalid Date, Pharmacyte Biotech (NASDAQ: PMCB) reported Q4 2023 earnings per share (EPS) of -$0.65, up 1,525% year over year. Total Pharmacyte Biotech earnings for the quarter were -$5.62 million. In the same quarter last year, Pharmacyte Biotech's earnings per share (EPS) was -$0.04.

If you're new to stock investing, here's how to buy Pharmacyte Biotech stock.

What was PMCB's earnings growth in the past year?

As of Q2 2024, Pharmacyte Biotech's earnings has grown year over year. Pharmacyte Biotech's earnings in the past year totalled -$11.51 million.

What was PMCB's revenue last quarter?

On Invalid Date, Pharmacyte Biotech (NASDAQ: PMCB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Pharmacyte Biotech's revenue was $0.00.

What was PMCB's revenue growth in the past year?

As of Q2 2024, Pharmacyte Biotech's revenue has grown null year over year. Pharmacyte Biotech's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.